The group is engaged in the development of innovative therapeutic solutions using different nanocarriers and nanoformulations. This strategy provides an outstanding platform to improve pharmacokinetics and modulate ADMET properties, mainly water solubility, membrane permeability and metabolic stability.

The project is sustained by strong collaborations with national and international organisations and by the European Technology Platform on Nanomedicine.

Selected publications